Frédéric Vely

8.1k total citations · 1 hit paper
72 papers, 4.6k citations indexed

About

Frédéric Vely is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Frédéric Vely has authored 72 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Immunology, 12 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Frédéric Vely's work include Immune Cell Function and Interaction (39 papers), T-cell and B-cell Immunology (23 papers) and Galectins and Cancer Biology (8 papers). Frédéric Vely is often cited by papers focused on Immune Cell Function and Interaction (39 papers), T-cell and B-cell Immunology (23 papers) and Galectins and Cancer Biology (8 papers). Frédéric Vely collaborates with scholars based in France, United States and Switzerland. Frédéric Vely's co-authors include Éric Vivier, Jacques A. Nunès, Mathieu Bléry, Mikaël Ebbo, Lucia Olcese, Adeline Crinier, Alessandro Moretta, N. Schleinitz, Anna Cambiaggi and Jean‐Robert Harlé and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Frédéric Vely

69 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural Killer Cell Signaling Pathways

2004 562 citations Éric Vivier, Frédéric Vely et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frédéric Vely France	35	3.4k	938	760	513	394	72	4.6k
Cédric Auffray France	25	4.1k 1.2×	1.3k 1.4×	879 1.2×	547 1.1×	218 0.6×	40	5.8k
Xuyu Zhou China	26	5.1k 1.5×	981 1.0×	1.1k 1.5×	431 0.8×	260 0.7×	64	6.4k
Tony Muchamuel United States	19	2.6k 0.8×	1.3k 1.4×	797 1.0×	501 1.0×	378 1.0×	36	4.6k
Philip J. Lucas United States	23	4.5k 1.3×	713 0.8×	1.1k 1.5×	397 0.8×	449 1.1×	32	5.6k
Lars Rogge France	33	2.8k 0.8×	1.2k 1.2×	844 1.1×	366 0.7×	299 0.8×	77	4.5k
Anthony R. French United States	33	4.3k 1.3×	696 0.7×	861 1.1×	932 1.8×	594 1.5×	66	5.5k
Federica Calzetti Italy	33	2.9k 0.8×	962 1.0×	895 1.2×	405 0.8×	163 0.4×	60	4.3k
Matthieu Rouleau France	27	3.0k 0.9×	2.0k 2.2×	752 1.0×	438 0.9×	221 0.6×	60	5.7k
Malek Kamoun United States	39	3.1k 0.9×	927 1.0×	870 1.1×	429 0.8×	397 1.0×	162	5.5k
Motoko Y. Kimura Japan	32	4.7k 1.4×	1.2k 1.3×	1.1k 1.4×	311 0.6×	236 0.6×	71	6.0k

Countries citing papers authored by Frédéric Vely

Since Specialization

Citations

This map shows the geographic impact of Frédéric Vely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Vely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Vely more than expected).

Fields of papers citing papers by Frédéric Vely

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Vely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Vely. The network helps show where Frédéric Vely may publish in the future.

Co-authorship network of co-authors of Frédéric Vely

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Vely. A scholar is included among the top collaborators of Frédéric Vely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Vely. Frédéric Vely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ancel, Patricia, Anne Dutour, Christelle Pipéroglou, et al.. (2024). Human epicardial fat has a beige profile and contains higher type 2 innate lymphoid cells than subcutaneous fat. Obesity. 32(7). 1302–1314. 4 indexed citations

Vely, Frédéric, et al.. (2024). Systematic review of phenotypes and genotypes of patients with gastrointestinal defects and immunodeficiency syndrome-1 (GIDID1) (related to TTC7A). Intractable & Rare Diseases Research. 13(2). 89–98.

Boutière, Clémence, Audrey Rico, Frédéric Vely, et al.. (2024). Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 11(3). e200231–e200231. 2 indexed citations

Boucraut, José, Aude‐Marie Grapperon, Laure Farnault, et al.. (2023). Clinical, biological, electrophysiological and therapeutic profile of patients with anti-MAG neuropathy according to MYD88L265P and CXCR4 mutations and underlying haemopathy. Journal of Neurology. 271(3). 1320–1330. 1 indexed citations

Rico, Audrey, Clémence Boutière, Frédéric Vely, et al.. (2023). Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 10(5). 22 indexed citations

Barlési, Fabrice, Laurent Greillier, F. Monville, et al.. (2020). LBA53 Precision immuno-oncology for advanced non-small cell lung cancer (NSCLC) patients (pts) treated with PD1/L1 immune checkpoint inhibitors (ICIs): A first analysis of the PIONeeR study. Annals of Oncology. 31. S1183–S1183. 9 indexed citations

Martinot, M., Valentin Greigert, Catherine Farnarier, et al.. (2019). Spinal cord toxoplasmosis in a young immunocompetent patient. Infection. 48(2). 299–302. 11 indexed citations

Colombo, Marina, Meriem Messaoudene, Sylvie Rusakiewicz, et al.. (2017). Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAF V600E Melanoma Lines with Vemurafenib. Cancer Immunology Research. 5(7). 582–593. 18 indexed citations

Narni-Mancinelli, Émilie, Baptiste N. Jaeger, Claire Bernat, et al.. (2012). Tuning of Natural Killer Cell Reactivity by NKp46 and Helios Calibrates T Cell Responses. Science. 335(6066). 344–348. 150 indexed citations

10.

Chiche, L., Jean-Marie Forel, G. Thomas, et al.. (2011). The Role of Natural Killer Cells in Sepsis. BioMed Research International. 2011(1). 986491–986491. 75 indexed citations

11.

Harhouri, Karim, Benjamin Guillet, Alexandrine Foucault‐Bertaud, et al.. (2010). Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia. Blood. 115(18). 3843–3851. 72 indexed citations

12.

Schleinitz, N., Frédéric Vely, Jean‐Robert Harlé, & Éric Vivier. (2010). Natural killer cells in human autoimmune diseases. Immunology. 131(4). 451–458. 113 indexed citations

13.

Nedvetzki, Shlomo, Stefanie Sowinski, Robert A. Eagle, et al.. (2007). Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood. 109(9). 3776–3785. 209 indexed citations

14.

Stewart, Charles A., Frédéric Vely, Xavier Saulquin, et al.. (2005). Recognition of peptide–MHC class I complexes by activating killer immunoglobulin-like receptors. Proceedings of the National Academy of Sciences. 102(37). 13224–13229. 320 indexed citations

15.

Chiesa, Sabrina, Elena Tomasello, Éric Vivier, & Frédéric Vely. (2004). Coordination of activating and inhibitory signals in natural killer cells. Molecular Immunology. 42(4). 477–484. 45 indexed citations

16.

Falco, Michela, Emanuela Marcenaro, Elisa Romeo, et al.. (2004). Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. European Journal of Immunology. 34(6). 1663–1672. 91 indexed citations

17.

Vely, Frédéric, Marie‐Alix Peyrat, Jean‐François Morcet, et al.. (2001). Regulation of Inhibitory and Activating Killer-Cell Ig-Like Receptor Expression Occurs in T Cells After Termination of TCR Rearrangements. The Journal of Immunology. 166(4). 2487–2494. 72 indexed citations

18.

Dréan, Eric Le, Frédéric Vely, Lucia Olcese, et al.. (1998). Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. European Journal of Immunology. 28(1). 264–276. 199 indexed citations

19.

Vely, Frédéric, Nadège Gruel, Janine Moncuit, et al.. (1997). A New Set of Monoclonal Antibodies Against Human FcγRII (CD32) and FcγRIII (CD16): Characterization and Use in Various Assays. Hybridoma. 16(6). 519–528. 35 indexed citations

20.

Renard, Valéry, Anna Cambiaggi, Frédéric Vely, et al.. (1997). Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Immunological Reviews. 155(1). 205–221. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact